⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 14, 2024Open Access

Supplementary Figure 3 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC

Lanlan Pang Yihua Huang Weitao Zhuang Yaxiong Zhang Jun Liao Yue Hao Feng Hao Guoqian Wang Ze-xin Chase Chen Yu Zhu Mengzhen Li Zhengbo Song Bo Peng Deng Jing Li Li Zhang Wenfeng Fang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure 3. Genomic characteristics was found between patients receiving afatinib or the third-generation EGFR-TKIs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pang et al. (2024) studied this question.

synapsesocial.com/papers/68e64c4bb6db6435875dcf8f https://doi.org/10.1158/1078-0432.26037492.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 3 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC2024
2Supplementary Figure 2 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC2024
3Supplementary Figure 2 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC2024
4Supplementary Figure 5 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC2024
5Supplementary Figure 5 from Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC2024